COMP <GO>
HTFL vs MMED // ENTERPRISE SCALE & MARKET CAP
Heartflow Inc. (NASDAQ) VS. MiniMed Group Inc. (NASDAQ) • 15-METRIC TALLY: HTFL 5
— MMED 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MMED
LAST: $54.49 (-7.72%) • MKT CAP: $5.13B
market-cap
$5.13B
LAST: $18.90 (+3.39%) • MKT CAP: $5.14B
market-cap
$5.14B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HTFL VS. MMED)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HTFL | MMED | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 76.80% | 54.20% | +22.60 | HTFL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.00% | -3.90% | -8.10 | MMED | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.12% | -7.75% | +6.63 | HTFL | /fcf-yield <GO> |
| Operating Margin | -36.40% | -6.10% | -30.30 | MMED | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -10.70% | -49.30 | MMED | /net-margins <GO> |
| Revenue Growth (YoY) | 39.90% | 14.30% | +25.60 | HTFL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 4.82 | +21.18 | HTFL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.0 | 44.5 | +19.50 | HTFL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.05 | -0.15 | MMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 24.0x | +3.00 | MMED | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.13B | $5.14B | -$8.5M | MMED | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HTFL REV | MMED REV | HTFL GROSS % | MMED GROSS % | HTFL FCF | MMED FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $176.0M | $3.10B | 76.8% | 54.2% | -$59.0M | -$420.0M |
| FY 2024 | $125.8M | $2.71B | 75.1% | 56.3% | -$73.4M | -$53.0M |
| FY 2023 | $87.2M | $2.47B | — | — | -$80.4M | -$70.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HTFL // BETA 0.90
MMED // BETA 1.05